background dyslipidemia is associated with cardiovascular morbidities and mortality. currently, fasting lipid profile determination is used to monitor treatment response. recently, postprandial lipemia is of increasing interest because of its atherogenic and thrombogenic potential and also was found to be more predictive for cardiovascular diseases. objectives to demonstrate postprandial lipemi...

Dyslipidemia has been recognized as an important risk-factor for the development of cardiovascular disease. The current, available therapies of dyslipidemia, their effectiveness, costs, cost-effectiveness and healthcare implications are discussed. At the present time, the lipid-lowering therapies are dominated by statins. Despite a variety of assumptions regarding modeling cardiovascular diseas...

Metabolic syndrome is a condition of at least three of the cardiovascular risk factors: obesity, excessive visceral fat storage, dyslipidemia, hypertension and hyperglycaemia or Type 2 diabetes. It is a state of insulin resistance, oxidative stress and chronic inflammation. Cardiovascular disease is the highest cause of death globally. Certain dietary components and over 800 plants help prevent...

X-ray fluoroscopy is routinely used in patients to guide vascular and cardiac interventions, because of the ability to perform real-time imaging and easy access to patients during interventions (Athanasoulis, 2001; Lakhan et al., 2009; Sousa et al., 2005). X-ray fluoroscopy, however, is limited for defining soft tissue and obtaining functional information. The poor contrast between pathologic a...

Cai, Dongqing, Munira Xaymardan, Jacquelyne M. Holm, Jingang Zheng, Jorge R. Kizer, and Jay M. Edelberg. Age-associated impairment in TNFcardioprotection from myocardial infarction. Am J Physiol Heart Circ Physiol 285: H463–H469, 2003. First published May 8, 2003; 10.1152/ajpheart.00144.2003.—Age-associated dysfunction in cardiac microvascular endothelial cells with impaired induction of cardio...